Key Points
-
Subclinical hypothyroidism among children is often a benign and remitting condition, for which risk of progression to overt hypothyroidism depends on the underlying cause (for example, autoimmune disease)
-
The optimum management of children with subclinical hypothyroidism depends on the aetiology and degree of TSH elevation and should be individually tailored
-
The benefits of levothyroxine therapy are clear for the severe forms of subclinical hypothyroidism; however, uncertainty about this approach still exists for the mild forms of the condition
-
In the absence of therapeutic intervention, clinical evaluation and thyroid function tests should be regularly performed to ensure early identification of children who might benefit from treatment
-
Growth and neurocognitive outcomes do not seem to be affected in mild subclinical hypothyroidism; however, subtle proatherogenic abnormalities have been detected among children with modest elevations of TSH concentration
-
Cardiovascular risk assessment among children and adolescents with subclinical hypothyroidism could help to prevent cardiovascular disease in adulthood
Abstract
Subclinical hypothyroidism is defined as serum levels of TSH above the upper limit of the reference range, in the presence of normal concentrations of total T4 or free T4. This biochemical profile might be an indication of mild hypothyroidism, with a potential increased risk of metabolic abnormalities and cardiovascular disease recorded among adults. Whether subclinical hypothyroidism results in adverse health outcomes among children is a matter of debate and so management of this condition remains challenging. Mild forms of untreated subclinical hypothyroidism do not seem to be associated with impairments in growth, bone health or neurocognitive outcome. However, ongoing scientific investigations have highlighted the presence of subtle proatherogenic abnormalities among children with modest elevations in their TSH levels. Although current findings are insufficient to recommend levothyroxine treatment for all children with mild asymptomatic forms of subclinical hypothyroidism, they highlight the potential need for assessment of cardiovascular risk among children with this condition. Increased understanding of the early metabolic risk factors associated with subclinical hypothyroidism in childhood will help to improve the management of affected individuals.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Biondi, B. & Cooper, D. S. The clinical significance of subclinical thyroid dysfunction. Endocr. Rev. 29, 76–131 (2008).
Van Vliet, G. & Deladoëy, J. Interpreting minor variations in thyroid function or echostructure: treating patients, not numbers or images. Pediatr. Clin. North Am. 62, 929–942 (2015).
Karmisholt, J., Andersen, S. & Laurberg, P. Variation in thyroid function in subclinical hypothyroidism: importance of clinical follow-up and therapy. Eur. J. Endocrinol. 164, 317–323 (2011).
Canaris, G. J., Manowitz, N. R., Mayor, G. & Ridgway, E. C. The Colorado thyroid disease prevalence study. Arch. Intern. Med. 160, 526–534 (2000).
Duntas, L. H. & Wartofsky, L. Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence? Thyroid 17, 1075–1084 (2007).
Maratou, E. et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur. J. Endocrinol. 160, 785–790 (2009).
Cooper, D. S. & Biondi, B. Subclinical thyroid disease. Lancet 379, 1142–1154 (2012).
Cikim, A. S. et al. Evaluation of endothelial function in subclinical hypothyroidism and subclinical hyperthyroidism. Thyroid 14, 605–609 (2004).
Gao, N., Zhang, W., Zhang, Y. Z., Yang, Q. & Chen, S. H. Carotid intima-media thickness in patients with subclinical hypothyroidism: a meta-analysis. Atherosclerosis 227, 18–25 (2013).
Rodondi, N. et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304, 1365–1374 (2010).
Gencer, B. et al. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation 126, 1040–1049 (2012).
Razvi, S., Weaver, J. U., Vanderpump, M. P. & Pearce, S. H. The incidence of ischemic heart disease andmortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. J. Clin. Endocrinol. Metab. 95, 1734–1740 (2010).
Chaker, L. et al. Subclinical hypothyroidism and the risk of stroke events and fatal stroke: an individual participant data analysis. J. Clin. Endocrinol. Metab. 100, 2181–2191 (2015).
Gaber, J. R. et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid 22, 1200–1235 (2012).
Pearce, S. H. et al. 2013 ETA guideline: management of subclinical hypothyroidism. Eur. Thyroid J. 2, 215–228 (2013).
Monzani, A. et al. Endocrine disorders in childhood and adolescence. Natural history of subclinical hypothyroidism in children and adolescents and potential effects of replacement therapy: a review. Eur. J. Endocrinol. 168, R1–R11 (2012).
Cerbone, M. et al. Cardiovascular risk factors in children with long-standing untreated idiopathic subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 99, 2697–2703 (2014).
Cerbone, M. et al. Linear growth and intellectual outcome in children with long-term idiopathic subclinical hypothyroidism. Eur. J. Endocrinol. 164, 591–597 (2011).
Wasniewska, M. et al. Comparative evaluation of therapy with L-thyroxine versus no treatment in children with idiopathic and mild subclinical hypothyroidism. Horm. Res. Paediatr. 77, 376–381 (2012).
Cerbone, M. et al. Non-autoimmune subclinical hypothyroidism due to a mutation in TSH receptor: report on two brothers. Ital. J. Pediatr. 39, 5 (2013).
Wu, T., Flowers, J. W., Tudiver, F., Wilson, J. L. & Punyasavatsut, N. Subclinical thyroid disorders and cognitive performance among adolescents in the United States. BMC Pediatr. 6, 12 (2006).
Lazar, L. et al. Natural history of thyroid function tests over 5 years in a large pediatric cohort. J. Clin. Endocrinol. Metab. 94, 1678–1682 (2009).
Gopalakrishnan, S. et al. Goitrous autoimmune thyroiditis in a pediatric population: a longitudinal study. Pediatrics 122, e670–e674 (2008).
Brown, R. S. Autoimmune thyroiditis in childhood. J. Clin. Res. Pediatr. Endocrinol. 5 (Suppl. 1), 45–49 (2013).
Radetti, G. et al. The natural history of the normal/mild elevated TSH serum levels in children and adolescents with Hashimoto's thyroiditis and isolated hyperthyrotropinemia: a 3-year follow-up. Clin. Endocrinol. 76, 394–398 (2012).
Deladoëy, J., Ruel, J., Giguère, Y. & Van Vliet, G. Is the incidence of congenital hypothyroidism really increasing? A 20-year retrospective population-based study in Québec. J. Clin. Endocrinol. Metab. 96, 2422–2429 (2011).
Korada, S. M. et al. Difficulties in selecting an appropriate neonatal thyroid stimulating hormone (TSH) screening threshold. Arch. Dis. Child. 95, 169–173 (2010).
Rabbiosi, S. et al. Congenital hypothyroidism with eutopic thyroid gland: analysis of clinical and biochemical features at diagnosis and after re-evaluation. J. Clin. Endocrinol. Metab. 98, 1395–1402 (2013).
Leonardi, D. et al. Longitudinal study of thyroid function in children with mild hyperthyrotropinemia at neonatal screening for congenital hypothyroidism. J. Clin. Endocrinol. Metab. 93, 2679–2685 (2008).
Rapa, A. et al. Subclinical hypothyroidism in children and adolescents: a wide range of clinical, biochemical, and genetic factors involved. J. Clin. Endocrinol. Metab. 94, 2414–2420 (2009).
Nicoletti, A. et al. Thyrotropin-stimulating hormone receptor gene analysis in pediatric patients with non-autoimmune subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 94, 4187–4194 (2009).
Calebiro, D. et al. Frequent TSH receptor genetic alterations with variable signaling impairment in a large series of children with nonautoimmune isolated hyperthyrotropinemia. J. Clin. Endocrinol. Metab. 97, E156–E160 (2012).
Tenebaum-Raskover, Y. et al. Long-term outcome of loss-of-function mutations in thyrotropin receptor gene. Thyroid 25, 292–299 (2015).
Persani, L. et al. Genetics and phenomics of hypothyroidism due to TSH resistance. Mol. Cell. Endocrinol. 322, 72–82 (2010).
Cassio, A. et al. Current loss-of-function mutations in the thyrotropin receptor gene: when to investigate, clinical effects, and treatment. J. Clin. Res. Pediatr. Endocrinol. 5 (Suppl. 1), 29–39 (2013).
De Marco, G. et al. Identification and functional analysis of novel dual oxidase 2 (DUOX2) mutations in children with congenital or subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 96, E1335–E1339 (2011).
Van Vilert, G. How often should we screen children with Down's syndrome for hypothyroidism? Arch. Dis. Child. 90, 557–558 (2005).
King, K., O'Gorman, C. & Gallagher, S. Thyroid dysfunction in children with Down's syndrome: a literature review. Ir. J. Med. Sci. 183, 1–6 (2014).
Gibson, P. A. et al. Longitudinal study of thyroid function in Down's syndrome in the first two decades. Arch. Dis. Child. 90, 574–578 (2005).
Konings, C. H. et al. Plasma thyrotropin bioactivity in Down's syndrome children with subclinical hypothyroidism. Eur. J. Endocrinol. 144, 1–4 (2001).
Tonacchera, M. et al. TSH receptor and Gsα genetic analysis in children with Down's syndrome and subclinical hypothyroidism. J. Endocrinol. Invest. 26, 997–1000 (2003).
Mantovani, G., Spada, A. & Elli, F. M. Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues. Nat. Rev. Endocrinol. 12, 347–356 (2016).
Zimmermann, M. B. Iodine deficiency. Endocr. Rev. 30, 376–408 (2009).
Rosene, M. L. et al. Inihibition of type 2 iodothyronine diodinase underlies the elevated plasma TSH associated with amiodarone treatment. Endocrinology 151, 5961–5970 (2010).
Tomer, Y. & Menconi, F. Interferon induced thyroiditis. Best Pract. Res. Clin. Endocrinol. Metab. 23, 703–712 (2009).
Strolin Benedetti, M., Whomsley, R., Baltes, E. & Tonner, F. Alteration of thyroid hormone homeostasis by antiepileptic drugs in humans: involvement of glucuronosyltransferase induction. Eur. J. Clin. Phamacol. 61, 863–872 (2005).
Verrotti, A., Scardapane, A., Manco, R. & Chiarelli, F. Antiepileptic drugs and thyroid function. J. Pediatr. Endocrinol. Metab. 21, 401–408 (2008).
Ishiguro, H. et al. Long-term follow-up of thyroid function in patients who received bone marrow transplantation during childhood and adolescence. J. Clin. Endocrinol. Metab. 89, 5981–5986 (2004).
Ostroumova, E. et al. Subclinical hypothyroidism after radioiodine exposure: Ukrainian-American cohort study of thyroid cancer and other thyroid diseases after the Chernobyl accident (1998–2000). Environ. Health Perspect. 117, 745–750 (2009).
Ostroumova, E. et al. Measures of thyroid function among Belarusian children and adolescents exposed to Iodine-131 from the accident at Chernobyl nuclear plant. Environ. Health Perspect. 121, 865–871 (2013).
Reinher, T. et al. Thyroid function in the nutritionally obese child and adolescent. Curr. Opin. Pediatr. 23, 415–420 (2011).
Grandone, A. et al. Thyroid function derangement and childhood obesity: an Italian experience. BMC Endocr. Disord. 10, 8 (2010).
Reinehr, T., de Sousa, G. & Andler, W. Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids. J. Clin. Endocrinol. Metab. 91, 3088–3091 (2006).
Reinehr, T., Isa, A., de Sousa, G., Dieffenbach, R. & Andler, W. Thyroid hormones and their relation to weight status. Horm. Res. 70, 51–57 (2008).
Wolters, B., Lass, N. & Reinehr, T. TSH and free triiodothyronine concentrations are associated with weight loss in a lifestyle intervention and weight regain afterwards in obese children. Eur. J. Endocrinol. 168, 323–329 (2013).
Reinehr, T. Obesity and thyroid function. Mol. Cell. Endocrinol. 316, 165–171 (2010).
Pacifico, A., Anania, C., Ferraro, F., Andreoli, G. M. & Chiesa, C. Thyroid function in childhood obesity and metabolic comorbidity. Clin. Chim. Acta. 413, 396–405 (2012).
Wasniewska, M. et al. Prospective evaluation of the natural course of idiopathic subclinical hypothyroidism in childhood and adolescence. Eur. J. Endocrinol. 160, 417–421 (2009).
Lazarus, J. et al. 2014 European Thyroid Association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur. Thyroid J. 3, 76–94 (2014).
Aversa, T. et al. Underlying Hashimoto's thyroiditis negatively affects the evolution of subclinical hypothyroidism in children irrespective of other concomitant risk factors. Thyroid 25, 183–187 (2015).
Wasniewska, M. et al. Five-year prospective evaluation of thyroid function in girls with subclinical mild hypothyroidism of different etiology. Eur. J. Endocrinol. 173, 801–808 (2015).
Claret, C. et al. Subclinical hypothyroidism in the first years of life in patients with Down's syndrome. Pediatr. Res. 73, 674–678 (2013).
Chase, H. P., Garg, S. K., Cockerham, R. S., Wilcox, W. D. & Walravens, P. A. Thyroid hormone replacement and growth of children with subclinical hypothyroidism and diabetes. Diabet. Med. 7, 299–303 (1990).
Radetti, G. et al. The natural history of euthyroid Hashimoto's thyroiditis in children. J. Pediatr. 149, 827–832 (2006).
Horn, S. & Heuer, H. Thyroid hormone action during brain development: more questions than answers. Mol. Cell. Endocrinol. 315, 19–26 (2010).
Brown, R. S. Disorders of the thyroid gland in infancy, childhood and adolescence. Endotext http://www.endotext.org/chapter/disorders-of-the-thyroid-gland-in-infancy-childhood-and-adolescence/ (2012).
Pérez-Lobato, R. et al. Thyroid status and its association with cognitive functioning in healthy boys at 10 years of age. Eur. J. Endocrinol. 172, 129–139 (2015).
Ergür, A. T. et al. Neurocognitive functions in children and adolescents with subclinical hypothyroidism. J. Clin. Res. Pediatr. Endocrinol. 4, 21–24 (2012).
Aijaz, N. J. et al. Neurocognitive function in children with compensated hypothyroidism: lack of short term effects on or off thyroxin. BMC Endocr. Disord. 6, 2 (2006).
Gogakos, A. I., Duncan Bassett, J. H. & Williams, G. R. Thyroid and bone. Arch. Biochem. Biophys. 503, 129–136 (2010).
Abe, E. et al. TSH is a negative regulator of skeletal remodeling. Cell 115, 151–162 (2003).
Saggese, G., Bertelloni, S., Baroncelli, G. I., Costa, S. & Ceccarelli, C. Bone mineral density in adolescent females treated with L-thyroxine: a longitudinal study. Eur. J. Pediatr. 155, 452–457 (1996).
Di Mase, R. et al. Bone health in children with long-term idiopathic subclinical hypothyroidism. Ital. J. Pediatr. 38, 56 (2012).
Kahaly, G. J. & Dillmann, W. H. Thyroid hormone action in the heart. Endocr. Rev. 26, 704–728 (2005).
Danzi, S. & Klein, I. Thyroid disease and the cardiovascular system. Endocrinol. Metab. Clin. North Am. 43, 517–528 (2014).
Cappola, A. R. & Ladenson, P. W. Hypothyroidism and atherosclerosis. J. Clin. Endocrinol. Metab. 88, 2438–2444 (2003).
Biondi, B., Palmieri, E. A., Lombardi, G. & Fazio, S. Subclinical hypothyroidism and cardiac function. Thyroid 12, 505–510 (2002).
Taddei, S. et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J. Clin. Endocrinol. Metab. 88, 3731–3737 (2003).
Stary, H. C. et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92, 1355–1374 (1995).
Berenson, G. S., Srinivasan, S. R. & Nicklas, T. A. Atherosclerosis: a nutritional disease of childhood. Am. J. Cardiol. 82, 22T–29T (1998).
Paoli-Valeri, M. et al. Atherogenic lipid profile in children with subclinical hypothyroidism. An. Pediatr. (Barc.) 62, 128–134 (in Spanish) (2005).
Marwaha, R. K. et al. Dyslipidemia in subclinical hypothyroidism in an Indian population. Clin. Biochem. 4, 1214–1217 (2011).
Nader, N. S. et al. Relationships between thyroid function and lipid status or insulin resistance in a pediatric population. Thyroid 20, 1333–1339 (2010).
Zhang, J. et al. Serum thyrotropin is positively correlated with the metabolic syndrome components of obesity and dyslipidemia in Chinese adolescents. Int. J. Endocrinol. 2014, 289503 (2014).
Witte, T., Ittermann, T., Thamm, M., Riblet, N. B. & Völzke, H. Association between serum thyroid-stimulating hormone levels and serum lipids in children and adolescents: a population-based study of german youth. J. Clin. Endocrinol. Metab. 100, 2090–2097 (2015).
Ittermann, T., Thamm, M., Wallaschofski, H., Rettig, R. & Völzke, H. Serum thyroid-stimulating hormone levels are associated with blood pressure in children and adolescents. J. Clin. Endocrinol. Metab. 97, 828–834 (2012).
Chen, H. et al. Investigation of thyroid function and blood pressure in school-aged subjects without overt thyroid disease. Endocrine 41, 122–129 (2012).
Javed, A. et al. Association between thyrotropin levels and insulin sensitivity in euthyroid obese adolescents. Thyroid 25, 478–484 (2015).
Sawicka, B. et al. Relationship between metabolic parameters and thyroid hormones and the level of gastric peptides in children with autoimmune thyroid diseases. J. Pediatr. Endocrinol. Metab. 23, 345–354 (2010).
Mokha, J. S. et al. Utility of waist-to-height ratio in assessing the status of central obesity and related cardiometabolic risk profile among normal weight and overweight/obese children: the Bogalusa Heart Study. BMC Pediatr. 10, 73 (2010).
Canas, J. A., Sweeten, S. & Balagopal, P. B. Biomarkers for cardiovascular risk in children. Curr. Opin. Cardiol. 28, 103–114 (2013).
Bossowski, A. et al. Analysis of serum adiponectin, resistin and leptin levels in children and adolescents with autoimmune thyroid disorders. J. Pediatr. Endocrinol. Metab. 23, 369–377 (2010).
Fonseca, V., Guba, S. C. & Fink, L. M. Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosis. Endocr. Rev. 20, 738–759 (1999).
Atabek, M. E., Pirgon, O. & Erkul, I. Plasma homocysteine concentrations in adolescents with subclinical hypothyroidism. J. Pediatr. Endocrinol. Metab. 16, 1245–1248 (2003).
Lekakis, J. et al. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 7, 411–414 (1997).
Cerbone, M. et al. Effects of L-thyroxine treatment on early markers of atherosclerotic disease in children with subclinical hypothyroidism. Eur. J. Endocrinol. 175, 11–19 (2016).
Boger, R. H. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the 'L-arginine paradox' and acts as a novel cardiovascular risk factor. J. Nutr. 134, 2842S–2847S (2004).
Çatli, G. et al. The effect of L-thyroxine treatment on left ventricular functions in children with subclinical hypothyroidism. Arch. Dis. Child. 100, 130–137 (2015).
Toscano, E. et al. Subclinical hypothyroidism and Down's syndrome; studies on myocardial structure and function. Arch. Dis. Child. 88, 1005–1008 (2003).
Dörr, H. G. et al. Levothyroxine treatment of euthyroid children with autoimmune Hashimoto thyroiditis: results of a multicenter, randomized, controlled trial. Horm. Res. Paediatr. 84, 266–274 (2015).
Özen, S., Berk, Ö., S¸ims¸ek, D. G. & Darcan, S. Clinical course of Hashimoto's thyroiditis and effects of levothyroxine therapy on the clinical course of the disease in children and adolescents. J. Clin. Res. Pediatr. Endocrinol. 3, 192–197 (2011).
Scarpa, V. et al. Treatment with thyroxine reduces thyroid volume in euthyroid children and adolescents with chronic autoimmune thyroiditis. Horm. Res. Paediatr. 73, 61–67 (2010).
Svensson, J. et al. Levothyroxine treatment reduces thyroid size in children and adolescents with chronic autoimmune thyroiditis. J. Clin. Endocrinol. Metab. 91, 1729–1734 (2006).
Cetinkaya, E., Aslan, A., Vidinlisan, S. & Ocal, G. Height improvement by L-thyroxine treatment in subclinical hypothyroidism. Pediatr. Int. 45, 534–537 (2003).
Çatlı, G., Anık, A., Ünver Tuhan, H., Böber, E., & Abacı, A. The effect of L-thyroxine treatment on hypothyroid symptom scores and lipid profile in children with subclinical hypothyroidism. J. Clin. Res. Pediatr. Endocrinol. 6, 238–244 (2014).
Author information
Authors and Affiliations
Contributions
M.S., D.C. and M.C researched the data for the article. M.S., D.C., M.C. and F.D.L. provided a substantial contribution to discussions of the content. M.S., D.C. and M.C. wrote the article. M.S., D.C., M.C. and F.D.L. reviewed and/or editing of the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Salerno, M., Capalbo, D., Cerbone, M. et al. Subclinical hypothyroidism in childhood — current knowledge and open issues. Nat Rev Endocrinol 12, 734–746 (2016). https://doi.org/10.1038/nrendo.2016.100
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2016.100
This article is cited by
-
Prospective study of thyroid function in the first year of life in infants with Down syndrome
European Journal of Pediatrics (2023)
-
Congenital hypothyroidism impairs spine growth of dentate granule cells by downregulation of CaMKIV
Cell Death Discovery (2021)
-
No association between subclinical hypothyroidism and dyslipidemia in children and adolescents
BMC Pediatrics (2020)
-
Elevated serum TSH concentrations are associated with higher BMI Z-scores in southern Iranian children and adolescents
Thyroid Research (2020)
-
What microRNAs could tell us about the human X chromosome
Cellular and Molecular Life Sciences (2020)